Tafenoquine succinate is an 8-aminoquinoline antimalarial medication primarily indicated for the radical cure and prevention of relapse in Plasmodium vivax malaria by eliminating dormant liver-stage parasites.… Read more



Tafenoquine succinate is an 8-aminoquinoline antimalarial medication primarily indicated for the radical cure and prevention of relapse in Plasmodium vivax malaria by eliminating dormant liver-stage parasites. This category provides essential analytical materials, including the active pharmaceutical ingredient, its identified process-related impurities, and stable isotope-labelled standards. These compounds are critical tools for pharmaceutical laboratories performing rigorous quality control, impurity profiling, and method validation. By utilizing these high-quality reference standards, researchers can ensure the accuracy of quantitative analysis throughout drug development and manufacturing processes. These materials support the detection and quantification of related substances, ensuring compliance with regulatory requirements and maintaining the safety and efficacy of the final pharmaceutical product.